You are viewing: Japan In Vitro Fertilization Market analysis
Part of: In Vitro Fertilization Market (Global)

The Japan In Vitro Fertilization Market was valued at $89.06 Million in 2024 and projected to reach to $157.11 Million by 2029, representing a compound annual growth rate of 12.0%. Japan's IVF market is poised for sustained expansion driven by demographic pressures and technological advancement.

Japan In Vitro Fertilization Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Japan In Vitro Fertilization Market Trends and Insights

  • This 12.0% compound annual growth rate reflects Japan's aging demographic profile, rising infertility rates, and increasing acceptance of assisted reproductive technologies.
  • Japan has emerged as a leader in reproductive medicine within Asia Pacific, driven by advanced healthcare infrastructure and government support for fertility treatments. The Japanese IVF market benefits from high healthcare spending, technological innovation, and evolving social attitudes toward family planning.
  • Between 2024 and 2029, Japan is expected to see sustained demand for fertility services as couples delay childbearing and seek medical intervention.
  • The market's expansion is supported by improved reimbursement policies, growing clinic networks, and enhanced patient awareness of treatment options available in Japan..

Key Market Statistics

  • CAGR (2024-2029) 12.0% CAGR
  • Market Size, 2024 ~USD 89.06 Million
  • Forecast, 2029 ~USD 157.11 Million
  • Country Japan

Japan In Vitro Fertilization Market Overview

Market Valuation & Growth :

Japan's IVF market reached USD 89.06 million in 2024 with a projected CAGR of 12.0%, expected to reach USD 157.11 million by 2029, outpacing the global growth rate of 11.7%.

Demographic Drivers :

Japan's aging population and declining birth rates have intensified infertility concerns, driving demand for assisted reproductive technologies and positioning IVF as a critical healthcare solution.

Regional Leadership :

Japan has established itself as a leader in reproductive medicine across Asia, with advanced clinical infrastructure, high success rates, and strong regulatory frameworks supporting IVF adoption.

Growing Social Acceptance :

Increasing cultural acceptance of assisted reproductive technologies, combined with improved insurance coverage and government support initiatives, has expanded patient accessibility to IVF treatments.

Japan In Vitro Fertilization Market Dynamics

  • The nation's aging society and low fertility rates create urgent demand for reproductive solutions, while Japanese healthcare providers continue investing in cutting-edge fertility treatments and personalized medicine approaches.
  • Government initiatives promoting family formation and expanding insurance reimbursement are expected to accelerate market penetration across urban and rural regions. By 2029, Japan's IVF market will benefit from enhanced clinical capabilities, rising patient awareness, and integration of AI-driven diagnostic tools.
  • The competitive landscape will intensify as both domestic and international fertility clinics expand operations.
  • Continued regulatory support and public health campaigns addressing infertility will sustain the 12% CAGR, positioning Japan as Asia's most mature and sophisticated IVF market..

Related Ecosystem

In Vitro Diagnostics

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Dna Microarrays
  • Assay Kits
  • Microarrays
Top Companies
  • ROCHE HOLDINGS AG
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Biomerieux s.a.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • CONMED Corporation

      Key Takeaways

      • Japan's IVF market is valued at USD 89.06 million in 2024 and will reach USD 157.11 million by 2029, representing a 12.0% CAGR.
      • Japan's aging population and delayed childbearing trends are driving increased demand for assisted reproductive technologies.
      • Advanced healthcare infrastructure and government support for fertility treatments position Japan as a regional leader in reproductive medicine.
      • Improved reimbursement policies and expanding clinic networks in Japan are accelerating market growth through 2029.

      In Vitro Fertilization Market Report Scope

      Report Metric Details
      Base Year 2024
      Fastest Growing Segment FROZEN NON-DONORS (Type)
      Forecast Period 2024-2029
      Growth Rate CAGR of 11.7% from 2024 to 2029
      Largest Segment EQUIPMENT (Product)
      Market Size Base Year (Billions) ~USD 0.95 (2024)
      Revenue Forecast (Billions) ~USD 1.65 (2029)
      Segments Covered Product, Type, Type Of Cycle, Procedure, End User

      Japan In Vitro Fertilization Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Product

      • Accessories
      • Anti-Vibration Tables
      • Cabinets
      • Cryosystems
      • Equipment
      • Gas Analyzers
      • Imaging Systems
      • Incubators
      • Laser Systems
      • Micromanipulator Systems
      • Microscopes
      • Other Equipment
      • Ovum Aspiration Pumps
      • Reagents & Media
      • Sperm Analyzer Systems
      • Sperm Separation Systems
      • Witness Systems

      By Type

      • Anti-Vibration Tables
      • Cabinets
      • Cryopreservation Media
      • Cryosystems
      • Embryo Culture Media
      • Gas Analyzers
      • Imaging Systems
      • Incubators
      • Laser Systems
      • Micromanipulator Systems
      • Microscopes
      • Other Equipment
      • Other Incubators
      • Ovum Aspiration Pumps
      • Ovum Processing Media
      • Sperm Analyzer Systems
      • Sperm Processing Media
      • Sperm Separation Systems
      • Time-Lapse Incubators
      • Witness Systems

      By Type Of Cycle

      • Fresh Donors
      • Fresh Non-Donors
      • Frozen Donors
      • Frozen Non-Donors

      By Procedure

      • Conventional Ivf
      • Ivf With Donar Eggs
      • Ivf With Icsi
      • Minimal Ivf
      • Other Procedures

      By End User

      • Cryobanks
      • Fertility Clinics & Ivf Centers
      • Hospitals & Surgical Centers
      • Hospitals & Surgical Clinics
      • Research Institutes

      Target Audience

      • Fertility Clinic Operators : Clinic owners and administrators need Japan-specific market data to benchmark performance, identify expansion opportunities, and optimize service offerings in a competitive regional landscape.
      • Medical Device & Pharmaceutical Companies : Manufacturers of IVF equipment, medications, and diagnostic tools require detailed Japan market insights to guide product development, regulatory strategy, and commercial launch planning.
      • Healthcare Investors & PE Firms : Investment professionals evaluating reproductive healthcare opportunities in Asia need validated market sizing and growth projections for Japan to assess portfolio fit and ROI potential.
      • Government & Policy Makers : Japanese health ministry officials and policymakers require market intelligence to inform fertility healthcare policies, insurance reimbursement frameworks, and public health initiatives.
      • Market Research & Consulting Firms : Research organizations and consultants need Japan-specific IVF market data to support client advisory services, competitive analysis, and strategic planning across the healthcare sector.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Obtain precise valuation data for Japan's IVF market (USD 89.06M in 2024) with verified 12% CAGR projections through 2029, enabling accurate financial forecasting and investment decisions.
      • Competitive Intelligence : Understand Japan's unique market dynamics, regulatory environment, and competitive positioning within Asia's reproductive medicine sector to identify partnership and expansion opportunities.
      • Demographic & Trend Analysis : Access insights into Japan's aging population, infertility rates, and cultural shifts driving IVF adoption, critical for tailoring products and services to this specific market.
      • Strategic Market Entry : Leverage comprehensive Japan-specific data to develop market entry strategies, identify key stakeholders, and assess reimbursement landscapes for fertility clinics and medical device manufacturers.
      • Investment & Funding Decisions : Make informed capital allocation decisions with validated market forecasts, growth drivers, and regional performance metrics specific to Japan's high-potential IVF sector.

      Frequently asked questions

      What is the current size of Japan's IVF market?

      Japan's In Vitro Fertilization market was valued at USD 89.06 million in 2024.

      What is the projected market size for Japan's IVF sector by 2029?

      Japan's IVF market is forecast to reach USD 157.11 million by 2029, growing at a 12.0% CAGR.

      What factors are driving growth in Japan's IVF market?

      Key drivers include Japan's aging demographic, delayed childbearing, rising infertility rates, advanced healthcare infrastructure, and improved government reimbursement policies for fertility treatments.

      How does Japan's IVF market compare to other Asia Pacific countries?

      Japan leads the Asia Pacific region in reproductive medicine due to its advanced healthcare system, high treatment acceptance rates, and strong regulatory framework for assisted reproductive technologies.

      What role does government policy play in Japan's IVF market expansion?

      Government support through improved reimbursement policies and regulatory frameworks has significantly enhanced accessibility and affordability of IVF treatments in Japan, driving market growth.

      RESEARCH METHODOLOGY

      In this research, the utilization of both primary and secondary sources was done to a great extent. This included studying the factors affecting the industry to find out the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and strategies by key players.

      Secondary Research

      The secondary research process involves methods using directories, databases such as D&B Hoovers, Bloomberg Businessweek, Factiva, white papers, annual reports, company filings, investor presentations, and SEC filings, and collation of the database of industry leaders. This would help in fleshing out basic information on key players and market segmentation based upon the trends of the industry at various levels, major developments in the market, and technological perspectives pertaining to the in vitro fertilization market.

      Primary Research

      Primary research for this report featured interviews with a cross-section of sources from both the supply and demand sides to generate qualitative and quantitative data. On the supply side, there were primary sources from industries represented by CEOs, vice presidents, marketing and sales directors, regional sales managers, technology and innovation directors, and other key executives from leading companies and organizations in product therapy markets. Primary sources on the demand side included but were not limited to: embryologists, clinicians, procurement managers, purchase managers, department heads, and professionals from hospitals, fertility clinics, in vitro fertilization centers, and reference labs, among others. This primary research was hoped to validate market segmentation, identify key market players, and get an overview of the key trends and dynamics of the industry.

      A breakdown of the primary respondents is provided below:

      In Vitro Fertilization Market Size, and Share

      To know about the assumptions considered for the study, download the pdf brochure

      *Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

      Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1  billion, Tier 2 = <USD 500 million, and Tier 3 = <USD 100 million.

      Market Estimation Methodology

      This report also presents the key players' revenue share analysis for the size of the in vitro fertilization market. The identification of key market participants and insights about their revenues in the in vitro fertilization sector are gathered through phases of primary and secondary research. The secondary research process relied heavily on top players' annual and financial reports, while primary research involved highly exhaustive interviews with key opinion leaders, viz., CEOs, directors, and senior marketing executives.

      The methodology adopted to calculate the global market value was on a segment basis. These segmental revenues were then sourced through the revenue data of major solution and service providers. The steps involved in the process are

      • Draw up a list of key global players operating in the in vitro fertilization market. Map the annual revenues accrued by players from the in vitro fertilization market or nearest reported business unit/ product category.
      • It represents the current major share of the global market as of 2022, using revenue mapping of the key players.

      Extrapolation to the global value for the in vitro fertilization market. Global In vitro fertilization Market: Bottom-Up Approach

      In Vitro Fertilization Market Size, and Share

      To know about the assumptions considered for the study, Request for Free Sample Report

      Global In vitro fertilization Market : Top-Down Approach

      In Vitro Fertilization Market Size, and Share

      In Vitro Fertilization Market Size, and Share

      Data Triangulation

      The in vitro fertilization market was segmented under various categories and subcategories using the above-mentioned methodology. Thereafter, proper data triangulation and the market segmentation process are carried out to further increase the accuracy of the data for each segment. Factors and trends from both the demand and supply sides were studied. Rigorous employment of both top-down and bottom-up approaches provided the result of the analysis of the in vitro fertilization market.

      Market Definition

      The in vitro fertilization market refers to the global landscape of Assisted Reproductive Technologies services and products that help a person or a couple conceive. It is a market that represents fertility clinics, hospitals, and even research institutions that provide in vitro fertilization treatments and related services, including medical devices, laboratory equipment, drugs, and consumables used for in vitro fertilization procedures. It also includes the diagnostic tests carried out prior to and in the course of in vitro fertilization, genetic screening technologies, and cryopreservation services. In vitro fertilization market has been used as a generic term describing the portfolio of diverse technologies, services, and products relating to the alleviation of infertility and the promotion of reproductive health.

      Key Stakeholders

      • Manufacturers and distributors of In vitro fertilization devices
      • Healthcare institutions (Hospitals and clinics)
      • Surgical centers
      • Healthcare institutions (hospitals and cardiac centers)
      • Research institutions
      • Clinical research organizations
      • Academic Medical Centers and Universities
      • Reference labs
      • Clinical research organizations
      • Accountable Care Organizations (ACOs)
      • Research and consulting firms
      • Contract research organizations (CROs) and contract manufacturing organizations (CMOs)
      • Academic medical centers and universities
      • Market research and consulting firms
      • Surgery Centers
      • Group Purchasing Organizations (GPOs)
      • Medical Research Laboratories
      • Academic Medical Centers and Universities

      Objectives of the Study

      • Define, describe, and forecast the In vitro fertilization market on Product, cycle, procedure, end user and region.
      • Analyze opportunities in the market for stakeholders and details of the competitive landscape for market leaders.
      • Detailed information regarding major factors influencing the market growth.
      • Analysis of the micro markets with respect to individual growth trends, prospects, and contribution to the total market.
      • Tracking and analysis of competitive developments such as new product launches and approvals, agreements, partnerships, expansions, acquisitions, and collaborations in the in vitro fertilization market.
      • Description of key companies operating in the market along with their market share analysis and core competencies

      Available Customizations

      With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global In vitro fertilization market

      Product Analysis

      • Product matrix, which gives a detailed comparison of the product portfolios of the top 5 companies.

      Company Information

      • Detailed analysis and profiling of additional market players (up to 5)

      Geographic Analysis

      • Further breakdown of the Rest of Europe's In vitro fertilization market: Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal among other
      • Further breakdown of the Rest of Asia Pacific In vitro fertilization market Singapore, Taiwan, New Zealand, Philippines, Malaysia, and other APAC countries
      • Further breakdown of the Rest of the world In vitro fertilization market: Latin America, MEA, and Africa

      Get the Full In Vitro Fertilization Market Report

      Full forecast, segment splits, and company analysis for all In Vitro Fertilization Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status